Jaguar Health Inc
NASDAQ:JAGX
Balance Sheet
Balance Sheet Decomposition
Jaguar Health Inc
Jaguar Health Inc
Balance Sheet
Jaguar Health Inc
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
8
|
1
|
1
|
3
|
3
|
8
|
17
|
5
|
6
|
8
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
8
|
17
|
5
|
6
|
8
|
|
| Cash Equivalents |
0
|
1
|
8
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
5
|
2
|
2
|
2
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
2
|
3
|
2
|
3
|
5
|
7
|
9
|
10
|
|
| Other Current Assets |
0
|
3
|
0
|
1
|
1
|
1
|
2
|
2
|
4
|
7
|
10
|
12
|
|
| Total Current Assets |
0
|
4
|
8
|
3
|
4
|
8
|
10
|
18
|
28
|
22
|
28
|
32
|
|
| PP&E Net |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
33
|
32
|
26
|
24
|
23
|
22
|
20
|
18
|
|
| Goodwill |
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
4
+1 429%
|
12
+181%
|
4
-71%
|
44
+1 125%
|
41
-6%
|
36
-11%
|
43
+18%
|
53
+24%
|
47
-11%
|
51
+7%
|
53
+5%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
1
|
1
|
1
|
7
|
5
|
5
|
5
|
5
|
6
|
5
|
5
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
2
|
5
|
3
|
4
|
7
|
9
|
4
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
2
|
2
|
4
|
11
|
7
|
4
|
3
|
16
|
5
|
12
|
|
| Other Current Liabilities |
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
3
|
4
|
4
|
15
|
27
|
15
|
13
|
15
|
30
|
14
|
20
|
|
| Long-Term Debt |
0
|
0
|
4
|
2
|
11
|
0
|
0
|
12
|
25
|
18
|
31
|
24
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Other Liabilities |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
1
N/A
|
5
+639%
|
8
+50%
|
6
-25%
|
26
+338%
|
27
+1%
|
16
-41%
|
26
+62%
|
42
+62%
|
48
+15%
|
46
-5%
|
44
-5%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
7
|
0
|
0
|
0
|
9
|
12
|
0
|
0
|
0
|
0
|
2
|
|
| Retained Earnings |
1
|
9
|
26
|
40
|
62
|
95
|
133
|
167
|
219
|
267
|
308
|
346
|
|
| Additional Paid In Capital |
0
|
1
|
30
|
38
|
80
|
100
|
142
|
184
|
231
|
267
|
314
|
354
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Total Equity |
0
N/A
|
1
-114%
|
4
N/A
|
2
N/A
|
17
N/A
|
14
-17%
|
21
+43%
|
17
-16%
|
12
-33%
|
1
N/A
|
5
N/A
|
10
+97%
|
|
| Total Liabilities & Equity |
0
N/A
|
4
+1 429%
|
12
+181%
|
4
-71%
|
44
+1 125%
|
41
-6%
|
36
-11%
|
43
+18%
|
53
+24%
|
47
-11%
|
51
+7%
|
53
+5%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
43
|
40
|
40
|
2
|
2
|
2
|
1
|
1
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
0
|
0
|
|